Comparison

Entecavir European Partner

Item no. HY-13623-5mg
Manufacturer MedChem Express
CASRN 142217-69-4
Amount 5 mg
Category
Type Inhibitors
Specific against other
Purity 98.88
Formula C12H15N5O3
Citations [1]Genovesi EV, et al. Efficacy of the carbocyclic 2'-deoxyguanosine nucleoside?BMS-200475?in the woodchuck model of hepatitis B virus infection. Antimicrob Agents Chemother.?1998 Dec;42(12):3209-18.<br>[2]Innaimo SF, et al. Identification of?BMS-200475?as a potent and selective inhibitor of hepatitis B virus. Antimicrob Agents Chemother. 1997 Jul;41(7):1444-9.<br>[3]Rivkin A, et al. A review of entecavir in the treatment of chronic hepatitis B infection. Curr Med Res Opin.?2005 Nov;21(11):1845-57.
Smiles NC(N1)=NC(C2=C1N([C@@H](C[C@H](O)[C@H]3CO)C3=C)C=N2)=O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias BMS200475; SQ34676
Available
Product Description
Entecavir (SQ 34676; BMS 200475) is a potent and selective inhibitor of HBV, with an EC50 of 3.75 nM in HepG2 cell.
StorageTemperature
-20°C (Powder, stored under nitrogen)
Shipping
Blue Ice
Manufacturers Applications
COVID-19-anti-virus
MolecularWeight
277.28
Clinical_Information
Launched
Manufacturers Research_Area
Infection; Cancer
Solubility
DMSO : ≥ 44 mg/mL
Manufacturers Target
HBV
Pathway
Anti-infection
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close